Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
Pulm Pharmacol Ther ; 54: 60-67, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30502381

RESUMEN

INTRODUCTION: Mucoactive agent, erdosteine, besides mucolytic activity, is characterized by many other pharmacodynamic properties which could be beneficial in the management of inflammatory conditions. BACKGROUND: Using guinea pig experimental model of allergic inflammation, we evaluated the ability of erdosteine to modulate airway defence mechanisms and inflammation after 10 days (10 mg/kg/day) administration. METHODS: In vivo changes in specific airway resistance and amplitude of tracheal contraction were estimated to evaluate the bronchodilatory effect. The sensitivity of chemically induced cough reflex was estimated via in vivo method. The ciliary beat frequency assessed on brushed tracheal cells was used as an indicator of the mucociliary clearance rate. The concentrations of the inflammatory cytokines IL-4, IL-5, IL-13 and IL-10 were measured in BALF using multiplex detecting method. RESULTS: Our data show that 10 days erdosteine administration resulted in bronchodilation and stimulation of ciliary beat frequency. Erdosteine did not affect the parameters of chemically induced cough reflex. Erdosteine demonstrated the modest decline in inflammatory cytokines IL-5, IL-13 and an increase in the concentration of IL-10, which is a potent regulator of inflammatory responses and plays a critical role in controlling allergic airway inflammation. CONCLUSION: In summary, we can state, that erdosteine is multi-action drug and it seems to have many beneficial and complementary effect in the management of chronic inflammatory airway diseases complicated by viscous mucus.


Asunto(s)
Broncodilatadores/farmacología , Citocinas/inmunología , Inflamación/tratamiento farmacológico , Tioglicolatos/farmacología , Tiofenos/farmacología , Animales , Líquido del Lavado Bronquioalveolar/inmunología , Tos/prevención & control , Modelos Animales de Enfermedad , Expectorantes/farmacología , Cobayas , Inflamación/inmunología , Masculino , Depuración Mucociliar
2.
Adv Exp Med Biol ; 1023: 1-10, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-28730380

RESUMEN

Erdosteine as a mucolytic agent that decreases mucus viscosity and facilitates mucus expulsion from the airways by cough or ciliary movement. Our objective was to determine whether erdosteine can directly contribute to mucus clearance. We addressed the issue by monitoring acute and chronic effects of erdosteine on ciliary beat frequency (CBF), cough sensitivity, and airway smooth muscle reactivity. The experiments were performed in healthy guinea pigs. Erdosteine (10 mg/kg) was administrated orally in a single dose or daily through 7 days. The cough reflex and specific airway resistance were evaluated in vivo. The CBF in tracheal brushed samples and the contractile response of tracheal smooth muscle stripes to bronchoconstrictive mediators were evaluated in vitro. We found that neither acute nor chronic erdosteine treatment had a significant effect on cough sensitivity and airway reactivity. However, in the vitro condition, erdosteine increased CBF and reduced tracheal smooth muscle contractility; the effects were more pronounced after chronic treatment. We conclude that erdosteine may directly contribute to mucus clearance by CBF stimulation. Although erdosteine has no effect on cough reflex sensitivity, its mild bronchodilator and mucolytic properties may promote effective cough.


Asunto(s)
Cilios/patología , Tos/tratamiento farmacológico , Hipersensibilidad Respiratoria/tratamiento farmacológico , Tioglicolatos/administración & dosificación , Tioglicolatos/uso terapéutico , Tiofenos/administración & dosificación , Tiofenos/uso terapéutico , Administración Oral , Animales , Cilios/efectos de los fármacos , Ácido Cítrico , Tos/fisiopatología , Relación Dosis-Respuesta a Droga , Cobayas , Histamina , Masculino , Reflejo/efectos de los fármacos , Hipersensibilidad Respiratoria/fisiopatología , Tráquea/efectos de los fármacos , Tráquea/fisiopatología
3.
Adv Exp Med Biol ; 921: 71-80, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27161110

RESUMEN

Expression of voltage-gated sodium channels (Nav) takes place in the airways and the role of Nav1.7 and Nav1.8 in the control of airway's defense reflexes has been confirmed. The activation of Nav channels is crucial for cough initiation and airway smooth muscle reactivity, but it is unknown whether these channels regulate ciliary beating. This study evaluated the involvement of Nav1.7 and Nav1.8 channels in the airway defense mechanisms using their pharmacological blockers in healthy guinea pigs and in the experimental allergic asthma model. Asthma was modeled by ovalbumin sensitization over a period of 21 days. Blockade of Nav1.7 channels significantly decreased airway smooth muscle reactivity in vivo, the number of cough efforts, and the cilia beat frequency in healthy animals. In the allergic asthma model, blockade of Nav1.8 efficiently relieved symptoms of asthma, without adversely affecting cilia beat frequency. The study demonstrates that Nav1.8 channel antagonism has a potential to alleviate cough and bronchial hyperreactivity in asthma.


Asunto(s)
Asma/patología , Cilios/fisiología , Tos/tratamiento farmacológico , Músculo Liso/fisiología , Mucosa Respiratoria/fisiología , Canales de Sodio Activados por Voltaje/química , Animales , Asma/inducido químicamente , Asma/tratamiento farmacológico , Asma/metabolismo , Cilios/efectos de los fármacos , Tos/inducido químicamente , Tos/metabolismo , Modelos Animales de Enfermedad , Cobayas , Hipersensibilidad/tratamiento farmacológico , Hipersensibilidad/etiología , Hipersensibilidad/metabolismo , Hipersensibilidad/patología , Masculino , Músculo Liso/efectos de los fármacos , Ovalbúmina/toxicidad , Mucosa Respiratoria/efectos de los fármacos , Bloqueadores de los Canales de Sodio/farmacología , Canales de Sodio Activados por Voltaje/metabolismo
4.
Adv Exp Med Biol ; 935: 25-34, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27329088

RESUMEN

The aim of this study was to determinate bronchodilator, antitussive, and ciliomodulatory activity of inhaled combination therapy with budesonide and salmeterol, and to correlate the results with the anti-inflammatory effect. The experiments were performed using two models of allergic inflammation (21 and 28 days long sensitization with ovalbumine) in guinea pigs. The animals were treated daily by aerosols of budesonide (1 mM), salmeterol (0.17 mM), and a half-dose combination of the two drugs. Antitussive and bronchodilator activities were evaluated in vivo. The ciliary beat frequency (CBF) was assessed in vitro in tracheal brushed samples, and inflammatory cytokines (IL-4, IL-5, IL-13, GM-CSF, and TNF-α) were determined in bronchoalveolar lavage fluid (BALF). We found that the combination therapy significantly decreased the number of cough efforts, airway reactivity, and the level of inflammatory cytokines in both models of allergic asthma. Three weeks long sensitization led to an increase in CBF and all three therapeutic approaches have shown a ciliostimulatory effect in order: salmeterol < budesonid < combination therapy. Four weeks long ovalbumine sensitization, on the other hand, decreased the CBF, increased IL-5, and decreased IL-13. In this case, only the combination therapy was able to stimulate the CBF. We conclude that a half-dose combination therapy of budesonide and salmeterol shows comparable antitussive, bronchodilator, and the anti-inflammatory effect to a full dose therapy with budesonide alone, but had a more pronounced stimulatory effect on the CBF.


Asunto(s)
Asma/tratamiento farmacológico , Broncodilatadores/farmacología , Budesonida/farmacología , Tos/tratamiento farmacológico , Inflamación/tratamiento farmacológico , Xinafoato de Salmeterol/farmacología , Animales , Asma/inducido químicamente , Asma/fisiopatología , Cilios/efectos de los fármacos , Cilios/fisiología , Tos/inducido químicamente , Tos/fisiopatología , Modelos Animales de Enfermedad , Sinergismo Farmacológico , Quimioterapia Combinada , Cobayas , Inflamación/inducido químicamente , Inflamación/fisiopatología , Masculino , Ovalbúmina/toxicidad
5.
Adv Exp Med Biol ; 921: 27-35, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27369295

RESUMEN

Overproduction of mucus is a hallmark of asthma. The aim of this study was to identify potentially effective therapies for removing excess mucus. The role of voltage-gated (Kir 6.1, KCa 1.1) and store-operated ion channels (SOC, CRAC) in respiratory cilia, relating to the tracheal ciliary beat frequency (CBF), was compared under the physiological and allergic airway conditions. Ex vivo experiments were designed to test the local effects of Kir 6.1, KCa 1.1 and CRAC ion channel modulators in a concentration-dependent manner on the CBF. Cilia, obtained with the brushing method, were monitored by a high-speed video camera and analyzed with ciliary analysis software. In natural conditions, a Kir 6.1 opener accelerated CBF, while CRAC blocker slowed it in a concentration-dependent manner. In allergic inflammation, the effect of Kir 6.1 opener was insignificant, with a tendency to decrease CBF. A cilio-inhibitory effect of a CRAC blocker, while gently reduced by allergic inflammation, remained significant. A KCa 1.1 opener turned out to significantly enhance the CBF under the allergic OVA-sensitized conditions. We conclude that optimally attuned concentration of KCa 1.1 openers or special types of bimodal SOC channel blockers, potentially given by inhalation, might benefit asthma.


Asunto(s)
Asma/patología , Cilios/fisiología , Inflamación/patología , Canales Iónicos/antagonistas & inhibidores , Mucosa Respiratoria/fisiología , Tráquea/fisiología , Animales , Asma/inducido químicamente , Asma/tratamiento farmacológico , Asma/metabolismo , Bloqueadores de los Canales de Calcio/farmacología , Cilios/efectos de los fármacos , Modelos Animales de Enfermedad , Cobayas , Hipersensibilidad/tratamiento farmacológico , Hipersensibilidad/etiología , Hipersensibilidad/metabolismo , Hipersensibilidad/patología , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Canales Iónicos/metabolismo , Masculino , Ovalbúmina/toxicidad , Mucosa Respiratoria/efectos de los fármacos , Tráquea/efectos de los fármacos
6.
Adv Exp Med Biol ; 838: 27-34, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25315622

RESUMEN

Our previous studies show that provinol, a polyphenolic compound, has anti-inflammatory activity during allergic inflammation. In the present study we investigated the effects of provinol and its combinations with clinically used antiasthmatics: budesonide or theophylline on airway defense mechanisms during experimental allergic asthma. Separate groups of guinea pigs were treated during the course of 21-day ovalbumin sensitization with provinol (20 mg/kg/day, p.o.), or budesonide (1 mM by inhalation), or theophylline (10 mg/kg/day, i.p.), and with a half-dose combination of provinol+budesonide or provinol+theophylline. Airways defense mechanisms: cough reflex and specific airway resistance (sRaw) were evaluated in vivo. Tracheal smooth muscle reactivity and mucociliary clearance were examined in vitro. The findings were that provinol caused significant decreases in sRaw and in tracheal smooth muscle contractility, a suppression of cough reflex, and positively modulated ciliary beat frequency. The bronchodilatory and antitussive effects of provinol were comparable with those of budesonide and theophylline. Provinol given as add-on treatment significantly potentiated the effects of budesonide or theophylline, although the doses of each were halved. We conclude that provinol not only has bronchodilatory and antitussive effects, but also potentiates similar effects exerted by budesonide and theophylline.


Asunto(s)
Antiasmáticos/farmacología , Antitusígenos/farmacología , Asma/tratamiento farmacológico , Broncodilatadores/farmacología , Pulmón/efectos de los fármacos , Polifenoles/farmacología , Administración por Inhalación , Administración Oral , Resistencia de las Vías Respiratorias/efectos de los fármacos , Animales , Asma/inducido químicamente , Asma/fisiopatología , Budesonida/farmacología , Sinergismo Farmacológico , Quimioterapia Combinada , Cobayas , Inyecciones Intraperitoneales , Pulmón/fisiopatología , Masculino , Músculo Liso/efectos de los fármacos , Ovalbúmina , Teofilina/farmacología , Técnicas de Cultivo de Tejidos
7.
Adv Exp Med Biol ; 838: 35-45, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25315623

RESUMEN

High-conductive calcium-sensitive potassium channels (BK+Ca) and ATP-sensitive potassium (K+ATP) channels play a significant role in the airway smooth muscle cell and goblet cell function, and cytokine production. The present study evaluated the therapeutic potential of BK+Ca and K+ATP openers, NS 1619 and pinacidil, respectively, in an experimental model of allergic inflammation. Airway allergic inflammation was induced with ovalbumine in guinea pigs during 21 days, which was followed by a 14-day treatment with BK+Ca and K+ATP openers. The outcome measures were airway smooth muscle cells reactivity in vivo and in vitro, cilia beating frequency and the level of exhaled NO (ENO), and the level of pro-inflammatory cytokines in the plasma and bronchoalveolar lavage fluid. The openers of both channels decreased airway smooth muscle cells reactivity, cilia beating frequency, and cytokine levels in the serum. Furthermore, NS1619 reduced ENO and inflammatory cells infiltration. The findings confirmed the presence of beneficial effects of BK+Ca and K+ATP openers on airway defence mechanisms. Although both openers dampened pro-inflammatory cytokines and mast cells infiltration, an evident anti-inflammatory effect was provided only by NS1619. Therefore, we conclude that particularly BK+Ca channels represent a promising new drug target in treatment of airway's allergic inflammation.


Asunto(s)
Resistencia de las Vías Respiratorias/efectos de los fármacos , Bencimidazoles/farmacología , Hiperreactividad Bronquial/tratamiento farmacológico , Canales KATP/agonistas , Canales de Potasio de Gran Conductancia Activados por el Calcio/agonistas , Moduladores del Transporte de Membrana/farmacología , Administración por Inhalación , Animales , Hiperreactividad Bronquial/inducido químicamente , Hiperreactividad Bronquial/metabolismo , Hiperreactividad Bronquial/fisiopatología , Líquido del Lavado Bronquioalveolar/química , Cilios/efectos de los fármacos , Citocinas/biosíntesis , Citocinas/metabolismo , Espiración , Cobayas , Canales KATP/metabolismo , Canales de Potasio de Gran Conductancia Activados por el Calcio/metabolismo , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Pulmón/fisiopatología , Masculino , Músculo Liso/efectos de los fármacos , Óxido Nítrico/biosíntesis , Ovalbúmina , Pinacidilo/farmacología , Pletismografía Total , Técnicas de Cultivo de Tejidos
8.
Adv Exp Med Biol ; 756: 39-48, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22836617

RESUMEN

Calcium release-activated calcium channels (CRAC) play unambiguous role in secretory functions of mast cells, T cells, and eosinophils. Less knowledge exists about the role of CRAC, widely distributed in airway smooth muscle (ASM) cells, in airway contractility. The presented study seeks to determine the possible participation of CRAC in ASM-based inflammatory airway disorders in guinea pigs. The acute and long-term administration (14 days) of the CRAC antagonist 3-fluoropyridine-4-carboxylic acid was used to examine the ASM contractility and associated reflexes in the guinea pig model of allergic airway inflammation by the following methods: (i) evaluation of specific airway resistance in vivo; (ii) evaluation of the contractile response of isolated ASM strips in vitro; and (iii) citric acid-induced cough reflex; (iv) measurement of exhaled NO levels (E(NO)). Allergic airway inflammation was induced by repetitive exposure of guinea pigs to ovalbumin (10(-6) M). The CRAC antagonist administered in a single dose to guinea pigs with confirmed allergic inflammation significantly reduced the cough response and the airway resistance, which corresponded with the findings in vitro. Long-term application of the CRAC antagonist had more strongly expressed effects. The results confirm the role of CRAC in the pathophysiology of experimental animal asthma and have a potential meaning for anti-asthma therapy.


Asunto(s)
Asma/tratamiento farmacológico , Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio/metabolismo , Hipersensibilidad/tratamiento farmacológico , Ácidos Isonicotínicos/farmacología , Contracción Muscular , Miocitos del Músculo Liso/fisiología , Animales , Antiasmáticos/farmacología , Calcio/metabolismo , Tos , Retículo Endoplásmico/metabolismo , Eosinófilos/metabolismo , Cobayas , Humanos , Masculino , Mastocitos/metabolismo , Contracción Muscular/efectos de los fármacos , Miocitos del Músculo Liso/efectos de los fármacos , Óxido Nítrico/análisis , Ovalbúmina/administración & dosificación , Sistema Respiratorio/efectos de los fármacos , Sistema Respiratorio/inmunología , Linfocitos T/metabolismo
9.
Adv Exp Med Biol ; 756: 49-55, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22836618

RESUMEN

The aim of the study was to prepare and evaluate the experimental model of allergic asthma. Changes in chough reflex, bronchoconstriction and the degree of inflammation were studied in ovalbumin (OVA) sensitized guinea pigs after 0, 7, 14, 21 days of exposure. The cough reflex was induced by citric acid inhalation in conscious animals in a double chamber body plethysmograph. Tracheal smooth muscle reactivity was assessed by examining the in vitro response to histamine (H) (10(-8)-10(-3) mol/l) and in vivo to H nebulization (10(-6) mol/l). BALF levels of IL-4, IL-5 and the eosinophil count were used as parameters of airway inflammation. After 7 days of OVA sensitization, there was an increase in tracheal smooth muscle contractility in vitro to cumulative concentration of H and an increase in cough parameters. After 14 days of OVA sensitization, there was a further increase in tracheal smooth muscle contractility to H, an increase in airway resistance, and a small increase in cough parameters. After 21 day of OVA sensitization, cough parameters were significantly reduced, airway resistance after H inhalation was increased, and there were significant increases in IL-4, IL-5, and eosinophils in BALF. In conclusion, progress in asthmatic inflammation during 21-day OVA sensitization caused a gradual increase in inflammatory mediators, a decline in cough reflex, and enhanced bronchoconstriction. This experimental model of allergic asthma can be used for pharmacological modulations of defense reflexes and inflammation.


Asunto(s)
Asma , Broncoconstricción , Modelos Animales de Enfermedad , Tráquea/inmunología , Resistencia de las Vías Respiratorias , Animales , Asma/inducido químicamente , Asma/inmunología , Asma/fisiopatología , Líquido del Lavado Bronquioalveolar/inmunología , Ácido Cítrico , Tos/inducido químicamente , Eosinófilos/inmunología , Cobayas , Histamina/farmacología , Interleucina-4/análisis , Interleucina-5/análisis , Masculino , Contracción Muscular/efectos de los fármacos , Músculo Liso/fisiopatología , Ovalbúmina , Reflejo , Tráquea/fisiopatología
10.
Bratisl Lek Listy ; 112(12): 670-5, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22372330

RESUMEN

AIM: The presented studies were aimed on experimental confirmation of Althaea officinalis polysaccharide rhamnogalacturonan antitussive effect and its changes in conditions of allergic inflammation. METHODS: We have tested whether rhamnogalacturonan inhibits cough reflex and modulates airways reactivity of guinea pigs in vivo. The cough in guinea pigs was induced by 0.3 M citric acid (CA) aerosol for 3 min interval, in which total number of cough efforts (sudden enhancement of expiratory flow accompanied by cough movement and sound) was counted. Specific airway resistance and its changes induced by citric acid aerosol were considered as an indicator of the in vivo reactivity changes. RESULTS: 1) Althaea officinalis polysaccharide rhamnogalacturonan dose- dependently inhibits cough reflex in unsensitized guinea pigs. Simultaneously, plant polysaccharide shortened the duration of antitussive effect when it was been tested in inflammatory conditions. 2) Rhamnogalacturonan did not influence airways reactivity in vivo conditions expressed as specific resistance values neither sensitized nor unsensitized groups of animals. 3) The antitussive activity of codeine (dose 10 mg.kg(-1) b.w. orally) tested under the same condition was comparable to higher dose of rhamnogalacturonan in unsensitized animals. 4) The characteristic cellular pattern of allergic airways inflammation was confirmed by histopathological investigations. CONCLUSION: Rhamnogalacturonan isolated from Althaea officinalis mucilage possesses very high cough suppressive effect in guinea pigs test system, which is shortened in conditions of experimentally induced airways allergic inflammation (Tab. 1, Fig. 4, Ref. 25). Full Text in free PDF www.bmj.sk.


Asunto(s)
Althaea , Antitusígenos/farmacología , Hiperreactividad Bronquial/fisiopatología , Tos/fisiopatología , Pulmón/patología , Extractos Vegetales/farmacología , Polisacáridos/farmacología , Tráquea/patología , Resistencia de las Vías Respiratorias , Animales , Hiperreactividad Bronquial/patología , Relación Dosis-Respuesta a Droga , Cobayas , Inflamación , Ovalbúmina/inmunología , Reflejo/efectos de los fármacos
11.
Eur J Med Res ; 14 Suppl 4: 78-81, 2009 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-20156731

RESUMEN

Some studies have suggested that the polyphenolic compounds might reduce the occurrence of asthma symptoms. The aim of our experiments was to evaluate the effects of 21 days of the flavonoid Flavin7 administration on experimentally induced airway inflammation in ovalbumin-sensitized guinea pigs. We assessed tracheal smooth muscle reactivity by an in vitro muscle-strip method; changes in airway resistance by an in vivo plethysmographic method; histological picture of tracheal tissue; and the levels of interleukin 4 (IL-4), and interleukin 5 (IL-5) in bronchoalveolar lavage fluid (BALF). Histological investigation of tracheal tissue and the concentrations of the inflammatory cytokines IL-4 and IL-5 in BALF were used as indices of airway inflammation. Administration of Flavin7 caused a significant decrease of specific airway resistance after histamine nebulization and a decline in tracheal smooth muscle contraction amplitude in response to bronchoconstricting mediators. Flavin7 minimized the degree of inflammation estimated on the basis of eosinophil calculation and IL-4 and IL-5 concentrations. In conclusion, administration of Flavin7 showed bronchodilating and anti-inflammatory effects on allergen-induced airway inflammation.


Asunto(s)
Hiperreactividad Bronquial/tratamiento farmacológico , Flavonoides/uso terapéutico , Ovalbúmina/inmunología , Estilbenos/uso terapéutico , Animales , Hiperreactividad Bronquial/inmunología , Citocinas/fisiología , Cobayas , Masculino
12.
Bratisl Lek Listy ; 110(5): 269-75, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19507659

RESUMEN

BACKGROUND: The ATP-sensitive potassium ion channels (K+ATP) are widely expressed on airway sensory nerves that mediate cough and other protective reflexes; dependent on airways smooth muscles (ASM) reactivity. OBJECTIVE: The study was conducted to determine the involvement of K+ATP in airway sensory nerves activity of different animal species. METHODS: In this study we have evaluated the cough reflex inhibiting potential and modulation of ASM reactivity in vitro, by K+ATP opener-pinacidil in guinea pig and cats. The cough in guinea pig was induced by administration, in cats by mechanical stimulation of the airways. ASM reactivity was tested by organ tissue both method of 0.3 M citric acid aerosol at 3 min interval. RESULTS: 1) Pinacidil inhibits cough reflex in guinea pigs which was antagonized when pre-treated with K+ATP blocker glibenclamide. 2) Pinacidil exhibited antitussive activity in cats comparable to codeine and was noticeably higher than dropropizine effects. 3) ASM reactivity was significantly abolished by pinacidil and almost completely antagonized by glibenclamide in guinea pigs. 4) Pinacidil significantly attenuated ASM contraction in cats only in highest concentrations of contractile mediators. CONCLUSION: K+ATP may be involved in mechanisms of cough reflex, likewise in antitussive activity of several more agents and also on defence reflexes dependent on ASM reactivity in different animal species such as guinea pigs and cats (Fig. 8, Ref. 20). Full Text (Free, PDF) www.bmj.sk.


Asunto(s)
Tos , Canales KATP/metabolismo , Reflejo/efectos de los fármacos , Animales , Antitusígenos/farmacología , Gatos , Ácido Cítrico , Tos/etiología , Femenino , Gliburida/farmacología , Cobayas , Canales KATP/agonistas , Masculino , Contracción Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Estimulación Física , Pinacidilo/farmacología , Bloqueadores de los Canales de Potasio/farmacología , Canales de Potasio/efectos de los fármacos , Glicoles de Propileno/farmacología , Tráquea
13.
Bratisl Lek Listy ; 110(8): 454-8, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19750980

RESUMEN

BACKGROUND: The anti-inflammatory, anti-allergic, antioxidant properties of flavonoids are known in the respiratory tract. We are interested in the role of Provinol during an allergic inflammation of the airway. OBJECTIVES: The aim of this study was to examine the influence of an acute administration of Provinol on tracheal smooth muscle reactivity in guinea pigs and to assess the involvement of nitric oxide in the mechanism of Provinol action. METHODS: This experiment was performed 14 days after the sensitization of animals by ovalbumin. In vivo, the specific airway conductance, as a tracheal smooth muscle reactivity parameter in response to bronchoconstrictor histamine, was evaluated after peroral administration of Provinol alone or together with L-NAME (N(omega)-nitro-L-arginine methyl ester). In vitro, Provinol alone or in combination with L-NAME were added into an organ baths before the supplement of direct bronchoconstrictor histamine, acetylcholine and the allergen ovalbumin in rising concentrations. The amplitude of the tracheal smooth muscle contraction, as a tracheal smooth muscle reactivity parameter in response to histamine, acetylcholine and ovalbumin was evaluated. RESULTS: Our results showed that a Provinol has significant bronchodilatory activities both in vivo and in vitro. CONCLUSION: Provinol alleviated the contraction of tracheal smooth muscle in guinea pigs sumin. Nitric oxide plays an important role in the mechanism of Provinol action (Fig. 2, Ref. 28n.(Fig. 2, Ref. 28).


Asunto(s)
Hiperreactividad Bronquial/tratamiento farmacológico , Flavonoides/uso terapéutico , Fenoles/uso terapéutico , Alérgenos , Animales , Hiperreactividad Bronquial/fisiopatología , Cobayas , Contracción Muscular/efectos de los fármacos , Ovalbúmina/inmunología , Polifenoles , Tráquea/efectos de los fármacos , Tráquea/fisiopatología , Vino/análisis
14.
J Physiol Pharmacol ; 58 Suppl 5(Pt 2): 673-83, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18204182

RESUMEN

In this study we investigated whether openers of potassium channels, K+ATP--pinacidil and BK+Ca--NS1619, modulate cough reflex and airway smooth muscle (ASM) reactivity in in vivo and in vitro conditions in guinea pigs. The cough reflex was induced by 0.3 M citric acid aerosol given for 3 min during which time a total number of coughs was counted. ASM reactivity in vivo was expressed as the values of specific airway resistance calculated by Pennock. Changes in ASM reactivity in vitro were tested by a tissue bath method. We found that both openers of potassium channels inhibit the citric acid-induced cough. ASM reactivity in vivo was significantly abolished by pinacidil and NS1619, which corresponded with the results of in vitro measurements. Pretreatment by selective blockers, K+ATP--glibenclamide and BK+Ca-tetraethylammonium prevented the above mentioned effects. The results indicate an important role of K+ATP and BK+Ca ion channels in defense reflexes of airways.


Asunto(s)
Tos/fisiopatología , Canales de Potasio/fisiología , Reflejo/fisiología , Acetilcolina/farmacología , Aerosoles , Resistencia de las Vías Respiratorias/efectos de los fármacos , Animales , Bencimidazoles/farmacología , Ácido Cítrico , Tos/inducido químicamente , Gliburida/farmacología , Cobayas , Histamina/farmacología , Canales KATP/antagonistas & inhibidores , Músculo Liso/efectos de los fármacos , Músculo Liso/fisiología , Pinacidilo/farmacología , Pletismografía , Bloqueadores de los Canales de Potasio/farmacología , Canales de Potasio/efectos de los fármacos , Canales de Potasio Calcio-Activados/efectos de los fármacos , Reflejo/efectos de los fármacos , Mecánica Respiratoria/efectos de los fármacos , Músculos Respiratorios/efectos de los fármacos , Músculos Respiratorios/fisiología , Fenómenos Fisiológicos Respiratorios/efectos de los fármacos , Vasodilatadores/farmacología
15.
J Physiol Pharmacol ; 58 Suppl 5(Pt 2): 493-500, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18204163

RESUMEN

The study was aimed at the assessment of the physiological range of phi and Tme/Te indices in children of up to 24 months of age, as based on noncalibrated respiratory inductive plethysmography performed in the supine position. We also examined the dependence of these indices on children's age and sex. The study was carried out in 127 healthy children. The results of the study indicate a significant decrease of phi in children aged 7-24 months in comparison with children of up to 6 months of age (P<0.001). Similarly, values of Tme/Te were found significantly higher in the group of older children (P<0.05). We did not find any appreciable sex differences in both measured parameters. The results of this study suggest that the Tme/Te index might be more stable, less age-dependent parameter of the Respitrace measurement than the phase angle j, but further research and analysis to achieve a correct verdict are warranted.


Asunto(s)
Envejecimiento/fisiología , Obstrucción de las Vías Aéreas/fisiopatología , Algoritmos , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Pletismografía/normas , Estándares de Referencia , Mecánica Respiratoria/fisiología , Caracteres Sexuales
16.
Bratisl Lek Listy ; 108(2): 93-9, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17685009

RESUMEN

BACKGROUND: The therapy of pathological type of cough presents serious medical problem. OBJECTIVES: The aim of experiments was to investigate polysaccacharide influence on experimentally induced cough. METHODS: The purified and/or modified polysaccharides from the flowers and plants, characterized by chemical composition and molecular properties were subjected to tests for antitussive activity on cough, induced mechanically in conscious cats of both sexes. RESULTS: The results revealed that the tested polysaccharides exhibited statistically significant cough-suppressing activity, which was noticeably higher than that of the non-narcotic drug used in clinical practice to treat coughing. The most expressive antitussive activity was observed with the polysaccharide from marsh mallow, containing the highest proportion of the uronic acid constituent. Negative influence of the tested compounds on expectoration was negligible when compared to that of codeine. CONCLUSION: Antitussive activity of various plant polysaccharides was confirmed. These results allow ranging them among prospective antitussive agents (Tab. 2, Fig. 6, Ref. 15) Full Text (Free, PDF) www.bmj.sk.


Asunto(s)
Althaea , Antitusígenos/uso terapéutico , Arctium , Tos/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Polisacáridos/uso terapéutico , Prunus , Animales , Gatos
17.
Int J Biol Macromol ; 69: 214-21, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24875316

RESUMEN

A dark brown polymeric complex was isolated from flowering parts of medicinal plant Arnica montana L. by hot alkaline extraction followed by neutralization and multi-step extractions with organic solvents. It was recovered in 5.7% yield, on GPC showed two peaks of molecular mass of 9 and 3.5kDa. The compositional analyses of Arnica complex revealed the presence of carbohydrates (26%), uronic acids (12%), phenolics (1.25mM or 213mg of GAE/1g), and low protein content (∼1%). The carbohydrate moiety was rich mainly in rhamnogalacturonan and arabinogalactan. The antitussive tests showed the reduction of the cough efforts by Arnica complex, however, its total antitussive effect was lower compared with that of codeine, the strongest antitussive agent. The bronchodilatory activity of Arnica complex was similar to salbutamol, a classic antiasthmatic drug, and was confirmed by significantly decreased values of specific airways resistance in vivo and by considerably attenuated the amplitude of acetylcholine and histamine-induced contractions in vitro. Arnica complex did not show any cytotoxic effect on mouse fibroblast cultures and human lung cells, up to the dose of 500µg/mL.


Asunto(s)
Antitusígenos/farmacología , Arnica/química , Extractos Vegetales/farmacología , Animales , Antitusígenos/química , Antitusígenos/aislamiento & purificación , Antitusígenos/uso terapéutico , Antitusígenos/toxicidad , Línea Celular , Ácido Cítrico/efectos adversos , Tos/inducido químicamente , Tos/tratamiento farmacológico , Cobayas , Humanos , Masculino , Ratones , Músculo Liso/efectos de los fármacos , Músculo Liso/fisiopatología , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/uso terapéutico , Extractos Vegetales/toxicidad , Reflejo/efectos de los fármacos , Sistema Respiratorio/efectos de los fármacos
18.
Int J Biol Macromol ; 52: 192-7, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23041666

RESUMEN

Polyphenolic-polysaccharide-protein complex has been isolated from flowers of Solidago canadensis L. by hot alkaline extraction procedure. Compositional analyses of S canadensis complex revealed the presence of carbohydrates (43 wt%), protein (27 wt%), phenolics (12 wt%), uronic acids (10 wt%) and inorganic material (8 wt%). The carbohydrate part was rich in neutral sugars (81 wt%) while uronids were determined in lower amount (19 wt%). Monosaccharide analysis of carbohydrate part revealed the presence of five main sugar components, i.e. rhamnose (~23 wt%), arabinose (~20 wt%), uronic acids (~19 wt%), galactose (~17 wt%) and glucose (~14 wt%), and indicated thus the presence of rhamnogalacturonan and arabinogalactan in S. canadensis complex. HPLC analysis of complex showed one single peak of molecule mass at 11.2 kDa. Antitussive activity tests, performed in three doses of Solidago complex, showed the reduction of the number of cough efforts in the dose-dependent manner. Higher doses (50 and 75 mg/kg b.w.) were shown to be by 15 and 20% more effective than that of lower one (25mg/kg b.w.). However, the antitussive effect of the highest dose (75 mg/kg b.w.) was by 10% lower in comparison with that of codeine, the strongest antitussive agent. Besides, the highest dose of the complex (75 mg/kg b.w.) significantly decreased values of specific airways resistance and their effect remained longer as that of salbutamol, a representative of classic antiasthmatic drugs.


Asunto(s)
Resistencia de las Vías Respiratorias/efectos de los fármacos , Antitusígenos , Broncodilatadores/farmacología , Tos/tratamiento farmacológico , Extractos Vegetales/farmacología , Solidago/química , Albuterol/química , Animales , Antitusígenos/química , Antitusígenos/farmacología , Broncodilatadores/química , Codeína/química , Codeína/farmacología , Relación Dosis-Respuesta a Droga , Cobayas , Extractos Vegetales/química
19.
Int J Biol Macromol ; 51(5): 794-9, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22829057

RESUMEN

A high molecular mass polysaccharide-polyphenolic conjugate has been isolated from flowering parts of Lythrum salicaria by hot alkaline extraction. Its chemical analysis revealed 74% of carbohydrates and 17% of phenolics. Compositional analysis of carbohydrate part showed a high GalA content (49%), Rha (25%), Gal (13%) and Ara (9%) residues, and indicated thus rhamnogalacturonan associated with arabinogalactan in Lythrum conjugate. Antitussive activity tests, performed in three doses of Lythrum conjugate - 25, 50 and 75 mg/kg of animal body weight, showed the reduction of the number of cough efforts even 5h after administration. However, their antitussive effects were lower in comparison with that of codeine, the strongest narcotic antitussive agent. The tests evaluating the influence of different doses on airways smooth muscle reactivity revealed more significant effect of Lythrum conjugate in comparison with that of salbutamol, a commercial bronchodilator used in a clinical practice. Measurements of specific airway resistance pointed at both, the dose-dependent bronchodilatory activity and possible participation of bronchodilation on antitussive effect of Lythrum conjugate. This study represents the first sight into pharmacodynamic properties of Lythrum polysaccharide-polyphenolic glycoconjugate.


Asunto(s)
Antitusígenos/química , Antitusígenos/farmacología , Broncodilatadores/química , Broncodilatadores/farmacología , Lythrum/química , Polifenoles/química , Polisacáridos/química , Animales , Antitusígenos/uso terapéutico , Broncodilatadores/uso terapéutico , Tos/tratamiento farmacológico , Cobayas , Masculino , Músculo Liso/efectos de los fármacos , Músculo Liso/fisiología , Sistema Respiratorio/efectos de los fármacos
20.
Biomed Pharmacother ; 2010 Oct 23.
Artículo en Inglés | MEDLINE | ID: mdl-21115321

RESUMEN

The Publisher regrets that this article is an accidental duplication of an article that has already been published, http://dx.doi.org/10.1016/j.bionut.2010.09.002. The duplicate article has therefore been withdrawn.

SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda